Hepatocellular carcinoma (HCC) is one of the most malignant cancer with high morbidity
and mortality which lead to a serious burden to society. AFP (alpha-fetoprotein) is the most …

An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

Hepatocellular carcinoma (HCC) is the most common liver malignancy and a leading cause
of cancer-related mortality worldwide. Accurate detection and differential diagnosis of early …

The role of α‐fetoprotein (AFP) in the surveillance and diagnosis of hepatocellular
carcinoma (HCC) has been questioned in recent years due to its low sensitivity and …

Over the past few decades, the screening for and early diagnosis of hepatocellular
carcinoma (HCC) has attracted attention worldwide, and especially in Asian countries such …

Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and
the third most frequent oncological cause of death. The incidence of HCC is on the increase …

The clinical value of Serum alpha-fetoprotein (AFP) to detect early hepatocellular carcinoma
(HCC) has been questioned due to its low sensitivity and specificity found in recent years …

Alpha fetoprotein (AFP) is the most widely used diagnostic and prognostic serum biomarker
for hepatocellular carcinoma (HCC). Despite its wide clinical use, a systematic …

Background: The present study aimed to systematically evaluate the diagnostic value of an
isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a …

Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death in
cirrhotic patients worldwide. The detection rate for early stage HCC remains low despite …